Lo último
People Over Profit | 7-mar-2017
People Over Profit Statement on the 17th Round of Negotiations of the Regional Comprehensive Economic Partnership (RCEP) in Kobe, Japan 27 Feb-3 March 2017
Lexology | 7-mar-2017
Since 2012, South Africa, dissatisfied with its bilateral investment treaties (BITs), has either been terminating or non-renewing several of these.
Lexology | 7-mar-2017
District court denies request to vacate award, finding that arbitrator was not partial and that tribunal did not exceed its authority in awarding damages for lost profits.
Kluwer Arbitration Blog | 7-mar-2017
After 15 years of absence in this type of negotiations and several claims the country faced since the economic and financial crisis of 2001, Argentina sat again in the BIT negotiation table.
Kluwer Arbitration Blog | 7-mar-2017
Two recently finalized cases against Latin America states provide several noteworthy points for further debates on the host states’ counterclaims towards investors.
Palabras clave:
Argentina ,
Ecuador ,
España ,
Estados Unidos ,
litigios inversionista-estado | ISDS
DNA | 6-mar-2017
Sitharaman clarified that the negotiation should not get lost in peripheral issues and should focus on bringing in promotion and protection elements.
S2B | 6-mar-2017
Position du réseau S2B sur la proposition de la Commission d’un mécanisme multilatéral de règlement des différends investisseurs-Etats (RDIE ou ISDS en anglais).
Globes | 4-mar-2017
The international arbitration panel ruled that Egypt failed to protect the Sinai pipeline from terrorists.
Palabras clave:
Egipto ,
energía ,
Israel ,
litigios inversionista-estado | ISDS ,
militarismo | terrorismo | seguridad
Open Canada | 3-mar-2017
NAFTA has its fair share of critics who want to see it updated. But if Trump has his way, a re-negotiated agreement may prove disappointing.
Palabras clave:
litigios inversionista-estado | ISDS ,
medio ambiente ,
TLCAN | T-MEC ,
trabajo | derechos laborales
MSF | 3-mar-2017
Médecins Sans Frontières (MSF) raises concerns over provisions under negotiation in the RCEP investment chapter that threaten to restrict access to affordable medicines for millions of people
